334 related articles for article (PubMed ID: 32839089)
1. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis.
Feng Y; Wang L; Lv H; Shi T; Xu C; Zheng H; Qi J; Zhao X; Li J; Gao Y; Qin C; Zhu Q
HPB (Oxford); 2021 Apr; 23(4):512-519. PubMed ID: 32839089
[TBL] [Abstract][Full Text] [Related]
2. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
[TBL] [Abstract][Full Text] [Related]
3. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study.
Wang X; Yu H; Zhao F; Xu Y; Wang C; Liu K; Liu B; Zheng H; Wei Y; Wang X; Zhu Q; Huang M; Feng Y
Eur J Radiol; 2023 Jul; 164():110860. PubMed ID: 37178491
[TBL] [Abstract][Full Text] [Related]
4. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
[TBL] [Abstract][Full Text] [Related]
5. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
Liu W; Zheng Y; He W; Zou R; Qiu J; Shen J; Yang Z; Zhang Y; Wang C; Wang Y; Zuo D; Li B; Yuan Y
Aliment Pharmacol Ther; 2018 Sep; 48(6):671-681. PubMed ID: 30063081
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis.
Suwa K; Seki T; Aoi K; Yamashina M; Murata M; Yamashiki N; Nishio A; Shimatani M; Naganuma M
Abdom Radiol (NY); 2021 Aug; 46(8):3790-3797. PubMed ID: 33675382
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
8. Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial).
Chong CCN; Lee KF; Cheung SYS; Chu CCM; Fong AKW; Wong J; Hui JWY; Fung AKY; Lok HT; Lo EYJ; Chan SL; Yu SCH; Ng KKC; Lai PBS
HPB (Oxford); 2020 Aug; 22(8):1121-1127. PubMed ID: 32044268
[TBL] [Abstract][Full Text] [Related]
9. The (Eternal) Debate on Microwave Ablation
Ricci AD; Rizzo A; Bonucci C; Tavolari S; Palloni A; Frega G; Mollica V; Tober N; Mazzotta E; Felicani C; Serra C; Brandi G
In Vivo; 2020; 34(6):3421-3429. PubMed ID: 33144450
[TBL] [Abstract][Full Text] [Related]
10. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Microwave and Radiofrequency Ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial.
Vogl TJ; Martin SS; Gruber-Rouh T; Booz C; Koch V; Nour-Eldin NA; Hussainy Said MN
Rofo; 2024 May; 196(5):482-490. PubMed ID: 38065541
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
13. Microwave ablation for peribiliary hepatocellular carcinoma: propensity score analyses of long-term outcomes.
Hu H; Chi JC; Liu R; Zhai B
Int J Hyperthermia; 2021; 38(1):191-201. PubMed ID: 33682598
[TBL] [Abstract][Full Text] [Related]
14. Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma.
Gaia S; Ciruolo M; Ribaldone DG; Rolle E; Migliore E; Mosso E; Vola S; Risso A; Fagoonee S; Saracco GM; Carucci P
Curr Oncol; 2021 Feb; 28(2):1034-1044. PubMed ID: 33669107
[TBL] [Abstract][Full Text] [Related]
15. Thermal ablation of medium-sized hepatocellular carcinomas using intraoperative ultrasound fusion imaging: A propensity score-matched analysis.
Luo L; He X; Li K; Long Y; Zeng Q; Tan L; Zheng R; Xu E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101581. PubMed ID: 33761441
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: A retrospective comparative study.
Lee KF; Wong J; Hui JW; Cheung YS; Chong CC; Fong AK; Yu SC; Lai PB
Asian J Surg; 2017 Jul; 40(4):301-308. PubMed ID: 26922631
[TBL] [Abstract][Full Text] [Related]
17. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
Chen S; Shi M; Shen L; Qi H; Wan W; Cao F; Xie L; Wu Y; Chen G; Mo J; Zhu G; Ye D; Zhang Y; Feng Z; Xu L; Fan W
Int J Hyperthermia; 2020; 37(1):384-391. PubMed ID: 32323585
[No Abstract] [Full Text] [Related]
18. Radiofrequency versus microwave ablation for hepatocellular carcinoma within the Milan criteria in challenging locations: a retrospective controlled study.
Han X; Ni JY; Li SL; Deng HX; Liang HM; Xu YY; Huang ZM; Zhang TQ; Huang JH
Abdom Radiol (NY); 2021 Aug; 46(8):3758-3771. PubMed ID: 34032898
[TBL] [Abstract][Full Text] [Related]
19. Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis.
Yang Y; Yu H; Qi L; Liu C; Feng Y; Qi J; Li J; Zhu Q
Int J Hyperthermia; 2022; 39(1):455-465. PubMed ID: 35271786
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Yu Q; Liu C; Navuluri R; Ahmed O
Abdom Radiol (NY); 2021 Sep; 46(9):4467-4475. PubMed ID: 33870454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
